Abstract 983: Design and methodology of LAPIS, an ongoing, phase III trial of neoadjuvant pamrevlumab (pam) with chemotherapy (CT) in patients (pts) with unresectable, locally advanced pancreatic cancer (LAPC)
Year: 2023
Type: conference-abstract
Source: Cancer Research
Authors: Vincent J. Picozzi, Syed Raza, Jack Li, Ewa Carrier
Institutions: Virginia Mason Medical Center, FibroGen (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4362595901